TERESA MULLINS: Open Payments
NPI 1801180724 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 31 payments from 10 companies in 2025. Trend: 2023 $329 · 2024 $426 · 2025 $719
Food & beverage: $719
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $140 |
| Ipsen Biopharmaceuticals, Inc | 1 | $129 |
| Madrigal Pharmaceuticals | 6 | $107 |
| Phathom Pharmaceuticals, Inc. | 4 | $95 |
| PFIZER INC. | 5 | $94 |
| Lilly USA, LLC | 3 | $53 |
| Celltrion USA Inc. | 2 | $39 |
| QOL Medical, LLC | 1 | $25 |
| Novo Nordisk Inc | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
Products named: XIFAXAN, IQIRVO, REZDIFFRA, VOQUEZNA, XELJANZ, MOUNJARO, VEGZELMA, Sucraid.
Industry payments across WV — which companies pay providers there.
